Showing results (331-340 of 468) with videos related to
Sort By:
Pageof 47
Journal of Clinical Microbiology|February 19, 2021
Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other ImmunoassaysGeorg Semmler, Marianna Theresia Traugott, Marianne Graninger, et al.Alimentary Pharmacology & Therapeutics|January 14, 2026
Characterisation and Prognostic Implication of Cholestasis After Burn InjuryLorenz Semmler, Georg Semmler, Andreas Langa, et al.Scientific Reports|April 20, 2018
Deviations of the immune cell landscape between healthy liver and hepatocellular carcinomaNataliya Rohr-Udilova, Florian Klinglmüller, Rolf Schulte-Hermann, et al.Journal of Viral Hepatitis|March 11, 2022
The 'Viennese epidemic' of acute HCV in the era of direct-acting antiviralsDavid Chromy, David J M Bauer, Benedikt Simbrunner, et al.Hepatology (Baltimore, Md.)|November 19, 2013
Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in miceYunching Chen, Yuhui Huang, Thomas Reiberger, et al.Hepatology (Baltimore, Md.)|November 4, 2015
The profile of platelet α-granule released molecules affects postoperative liver regenerationPatrick Starlinger, Stefanie Haegele, Florian Offensperger, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 8, 2020
Prognostic impact of sarcopenia in cirrhotic patients stratified by different severity of portal hypertensionRafael Paternostro, Constanze Bardach, Benedikt S Hofer, et al.Journal of Hepatology|July 16, 2026
A machine learning approach to non-invasive prediction of hepatic decompensation in compensated advanced chronic liver disease: the CIRI modelGeorg Kramer, Anders Hildeman, Caterina Tozzi, et al.Plos One|April 22, 2014
IFNL4 ss469415590 variant shows similar performance to rs12979860 as predictor of response to treatment against Hepatitis C Virus genotype 1 or 4 in CaucasiansLuis M Real, Karin Neukam, Rocío Herrero, et al.Liver International : Official Journal of the International Association for the Study of the Liver|June 7, 2014
Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3Mattias Mandorfer, Berit A Payer, Philipp Schwabl, et al.Pageof 47